Qiagen gets second therascreen CDx US approval as FDA OKs Iressa

The US FDA has given Qiagen the thumbs-up for its therascreen EGFR RGQ PCR kit, a companion diagnostic for AstraZeneca’s Iressa lung cancer therapy, which has also got approval from the agency.